These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8442283)

  • 1. Isolation of functional MHC class I-deficient islet cells.
    Osorio RW; Ascher NL; Jaenisch R; Natuzzi ES; Freise CE; Roberts JP; Stock PG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):968-9. PubMed ID: 8442283
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
    Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
    Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 4. Islets deficient in cell-surface class I MHC (B2M-/-) induce unresponsiveness in allogeneic recipients.
    Ninova D; Marjoribanks C; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3195. PubMed ID: 8539909
    [No Abstract]   [Full Text] [Related]  

  • 5. Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment.
    Jain K; Cai BR; Patel S; Anderson M; Miller D; Smith BH; Rubin AL; Suthanthiran M
    Transplant Proc; 1994 Dec; 26(6):3323-4. PubMed ID: 7998155
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):752. PubMed ID: 8171644
    [No Abstract]   [Full Text] [Related]  

  • 8. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J; Johnson Z; Kuhl N; Gill RG
    Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of islet allograft primary nonfunction.
    Liu M; Shapiro ME
    Transplant Proc; 1995 Dec; 27(6):3205-7. PubMed ID: 8539915
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for isolation of murine islets with markedly improved yields.
    Liu M; Shapiro ME
    Transplant Proc; 1995 Dec; 27(6):3208-10. PubMed ID: 8539916
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment.
    Gotoh M; Fukuzaki T; Dono K; Wada H; Kanai T; Monden M; Yagita H; Okumura K; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):973-4. PubMed ID: 8442286
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenic properties of fetal mouse proislets.
    Simeonovic CJ; Lafferty KJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):938-9. PubMed ID: 3152643
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cryopreservation on islet recovery and in vivo function.
    Cattral MS; Lakey JR; Warnock GL; Kneteman NM; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3336. PubMed ID: 8539978
    [No Abstract]   [Full Text] [Related]  

  • 15. Manipulation of pancreatic islet cells in allotransplantation.
    Tze WJ; Tai J
    Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
    [No Abstract]   [Full Text] [Related]  

  • 16. Cotransplanted hepatic stellate cells enhance vascularization of islet allografts.
    Yin Z; Wu W; Fung JJ; Lu L; Qian S
    Microsurgery; 2007; 27(4):324-7. PubMed ID: 17477430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of islet immunogenicity using an anti-MHC class I monoclonal antibody.
    Munn SR; Marjoribanks C
    Transplant Proc; 1992 Jun; 24(3):1038-9. PubMed ID: 1604509
    [No Abstract]   [Full Text] [Related]  

  • 18. Class I and class II antigens in the rejection of murine islet cell transplants.
    Hauptfeld V; Lacy PE; Graff RJ
    Transplant Proc; 1995 Dec; 27(6):3234-5. PubMed ID: 8539929
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation.
    Katz SM; Browne B; Phan T; Wang ME; Bennett CF; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Dec; 27(6):3214. PubMed ID: 8539920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new preservation solution increases islet yield and reduces graft immunogenicity in pancreatic islet transplantation.
    Giraud S; Claire B; Eugene M; Debre P; Richard F; Barrou B
    Transplantation; 2007 May; 83(10):1397-400. PubMed ID: 17519794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.